|
4 Companies |
|
3 Products |
|
3 Products |
|
11 Mechanisms of Action |
|
0 Trials |
|
21 News |
|
- | Enrollment change, Trial withdrawal, Trial primary completion date: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (clinicaltrials.gov) - Apr 28, 2017
P=N/A, N=0, Withdrawn, Sponsor: Sue O'Dorisio
N=30 --> 0 | Suspended --> Withdrawn | Trial primary completion date: Dec 2018 --> Mar 2017
- Trial primary completion date: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (clinicaltrials.gov) - Sep 8, 2016
P=N/A, N=30, Suspended, Sponsor: O'Dorisio, M S
N=30 --> 0 | Suspended --> Withdrawn | Trial primary completion date: Dec 2018 --> Mar 2017 Trial primary completion date: Jul 2016 --> Dec 2018
- Trial primary completion date: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (clinicaltrials.gov) - Jun 21, 2016
P=N/A, N=30, Suspended, Sponsor: O'Dorisio, M S
Trial primary completion date: Jul 2016 --> Dec 2018 Trial primary completion date: Jul 2015 --> Jul 2016
- Seprehvir (HSV1716) / Sorrento
Enrollment change, Trial termination, Trial primary completion date, Surgery: Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery (clinicaltrials.gov) - May 31, 2016
P1, N=2, Terminated, Sponsor: Pediatric Brain Tumor Consortium
Trial primary completion date: Jul 2015 --> Jul 2016 N=24 --> 2 | Recruiting --> Terminated | Trial primary completion date: Feb 2017 --> May 2016
- Enrollment change, Trial termination, Trial primary completion date: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas (clinicaltrials.gov) - Apr 21, 2016
P=N/A, N=1, Terminated, Sponsor: Andrei Iagaru
N=24 --> 2 | Recruiting --> Terminated | Trial primary completion date: Feb 2017 --> May 2016 N=50 --> 1 | Suspended --> Terminated | Trial primary completion date: Dec 2019 --> Aug 2015; Re-evaluate indication with the referring physicians
- Trial suspension: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=50, Suspended, Sponsor: Stanford University
N=50 --> 1 | Suspended --> Terminated | Trial primary completion date: Dec 2019 --> Aug 2015; Re-evaluate indication with the referring physicians Recruiting --> Suspended
- Trial suspension: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (clinicaltrials.gov) - Apr 22, 2015
P=N/A, N=30, Suspended, Sponsor: University of Iowa
Recruiting --> Suspended Recruiting --> Suspended
- Enrollment open, Trial primary completion date: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas (clinicaltrials.gov) - Dec 17, 2014
P=N/A, N=50, Recruiting, Sponsor: Stanford University
Recruiting --> Suspended Not yet recruiting --> Recruiting | Trial primary completion date: Jul 2019 --> Dec 2019
- Trial initiation date: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas (clinicaltrials.gov) - Nov 18, 2014
P=N/A, N=50, Not yet recruiting, Sponsor: Stanford University
Not yet recruiting --> Recruiting | Trial primary completion date: Jul 2019 --> Dec 2019 Initiation date: Jul 2014 --> Jan 2015
- Trial primary completion date: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (clinicaltrials.gov) - Oct 15, 2014
P=N/A, N=30, Recruiting, Sponsor: University of Iowa
Initiation date: Jul 2014 --> Jan 2015 Trial primary completion date: Jul 2014 --> Jul 2015
- Clinical: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (clinicaltrials.gov) - Jul 18, 2014
P=N/A, N=30, Recruiting, Sponsor: University of Iowa
- Clinical: 18F FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly Diagnosed or Recurrent Gliomas (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=50, Not yet recruiting, Sponsor: Stanford University
- | gefitinib / Generic mfg.
Trial completion: Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas (clinicaltrials.gov) - May 27, 2014
P1/2, N=69, Completed, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Jul 2014 --> Jul 2015 Active, not recruiting --> Completed
- gefitinib / Generic mfg.
Trial initiation date: Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas (clinicaltrials.gov) - Apr 21, 2014
P1/2, N=69, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Initiation date: Aug 2002 --> Jul 2002
- Trial termination: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer (clinicaltrials.gov) - Jan 30, 2014
P3, N=22, Terminated, Sponsor: University of South Florida
Initiation date: Aug 2002 --> Jul 2002 Active, not recruiting --> Terminated; The study was terminated due to slow accrual.
- Enrollment change: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer (clinicaltrials.gov) - Jan 30, 2014
P3, N=22, Terminated, Sponsor: University of South Florida
Active, not recruiting --> Terminated; The study was terminated due to slow accrual. N=178 --> 22
- Rytelo (imetelstat) / Geron
Enrollment change: Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma (clinicaltrials.gov) - Jan 28, 2014
P1, N=34, Completed, Sponsor: Children's Oncology Group
N=178 --> 22 N=45 --> 34
- | Rytelo (imetelstat) / Geron
Trial completion: Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma (clinicaltrials.gov) - Jan 28, 2014
P1, N=34, Completed, Sponsor: Children's Oncology Group
N=45 --> 34 Active, not recruiting --> Completed
- Seprehvir (HSV1716) / Sorrento
New P1 trial, Surgery: Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery (clinicaltrials.gov) - Jan 7, 2014
P1, N=24, Recruiting, Sponsor: Pediatric Brain Tumor Consortium
- Seprehvir (HSV1716) / Sorrento
Enrollment open, Surgery: Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery (clinicaltrials.gov) - Jan 6, 2014
P1, N=24, Recruiting, Sponsor: Pediatric Brain Tumor Consortium
Active, not recruiting --> Completed Not yet recruiting --> Recruiting